lindas have a posse
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NWBO are doing very well.
If you want to sell now then go ahead. I am sure there are many buyers ready to take that trade.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171161624
NWBO up 116% over 5 years!
XBI up only 0.2% over 5 years.
F up 27% over 5 years.
GM up 0.27% over 5 years
IBM down 5% over 5 years.
DAL down 21% over 5 years.
WBA down 46% over 5 years.
NWBO, with no revenue, performing better than entire biotech sector as well as companies with exponentially higher market caps!
How?
The market potential!
We can do it!
A prisoners dilemma, indeed, will be facing the criminal manipulators of NWBO stock.
NWBO management has not had a single trial failure!
All successful!
What other companies can say they've had the same amount of success with their immunotherapy pipeline?
They are the ONLY COMPANY to DEFEAT GLIOBLASTOMA!
We are on the cusp of approval!
To those who are feeling consternation:
Get the bottles popping!
Stop crying like your dog died!
Go read JAMA again!
Look at the potential!
Don't let yourself be gaslit into selling your pile of 24 karat gold for a box of lignite coal!
NWBO's IP will bring trillions in market cap through addressing all solid tumors!
https://pasteboard.co/VYt8YgzuEz08.jpg
$77 is where we will be at soon. Let's not let the incessant naysayers gaslight us to reducing the rational value of Northwest Biotherapeutics.
Billions in revenue from fully built out non Flaskworks Sawston. That's a single small factory with less than 100K square feet.
It's not about timing the market but time in the market.
Only a fool would lock in "gains" now with NWBO.
We will soon be over 9000%, Gary.
Landmark Trial Results!
MHRA Trial Endorsement (PIP)!
Innovative Manufacturing!
JAMA!
Global Patent Protection!
My 400K shares should be worth $30M once Northwest Biotherapeutics obtains global approval on nGBM and rGBM indications.
That may take some time but I see no reason to sell these shares since I can borrow against them once NWBO are off OTC. I also didn't get over my skis when making investment decisions.
In my personal opinion as a retail investor representing myself alone, and not providing investment advice, the false panic created on this forum daily simply does not reflect the deep value present in Northwest Biotherapeutics stock!
Billionaire Robert Hefner agrees:
Dr. Ashkan is the genius behind this viral vid of him performing brain surgery while his patient was awakened to play the violin…mid-surgery. He told me he champions DCVax-L bc of trial data along with what he’s seen first-hand from his patients. $NWBOhttps://t.co/XFTeSPFtH5
— Wade Kovash (@wkovash) June 6, 2022
Watch one of the world’s preeminent neurosurgeons explain the significance of $NWBO ‘s Phase III trial of DCVax-L. The results are groundbreaking and represent an enormous advancement in one of the most tragic cancers. https://t.co/eQw5tAsivK
— Wade Kovash (@wkovash) June 6, 2022
Trillion dollar market cap technology.
That's the power of DCVax!
Linda Powers developed DCVax-L, DCVax-D, and manufacturing all cheaper than the industry mean.
Wow, we really have a world-class management team at Northwest Biotherapeutics!
I agree X Master that DCVax will be approved soon due to the efforts of NWBO's world-class management team.
DCVax-L trials were done on indications other than GBM. There's also DCVax-Direct.
These were all successful trials so thank you for highlighting that management are much more effective than their peers in pharmaceutical industry.
The average R&D cost to bring a drug to market? About $1-2 billion dollars.
https://www.cbo.gov/publication/57126
NWBO management did quite well considering they developed the first autologous cancer vaccine as well as multiple manufacturing processes to develop the product. So given that context I think your conclusions are not rational.
I agree hope4patients.
NWBO longs will not stop supporting our world class management team.
Trillion dollar market cap technology.
NWBO, $120 a share 2024.
It seems like some want Linda Powers to take risky actions that could potentially bankrupt the company.
Alton Boynton, the genius who invented DCVax along with Linda Liau, will be remembered as a true scientific pioneer.
Statues of him will be erected at the nations top medical schools.
So glad he founded this amazing company Northwest Biotherapeutics!
Dave Innes, an expert at communications who instills confidence into even the most cynical investor.
So glad to have him on the Northwest Biotherapeutics team!
Marnix Bosch. The man with a lot of scientific plans.
So glad to have him as CTO!
Mike Scott, an excellent manager.
So glad Linda Powers hired him to manage Advent.
Les Goldman, genius advocate working on behalf of GBM patients.
Linda Powers, world-class CEO.
100B dollar company
The future is autologous
https://www.evaluate.com/node/18583/amp
I am an independent shareholder since 2020. You can attack me to distract the audience from the monumental achievements management delivered by defeating Glioblastoma.
I manipulated myself into a few good beers tonight and I think you will agree that Linda Powers remains an excellent CEO having defeated Glioblastoma as well as constructed an international supply chain to deliver the first autologous cancer vaccine for millions of patients worldwide.
They haven't sold a single share.
An absurd conclusion given your conspiracy has no exit strategy. They're still here ensuring NWBO dominates the greenfield autologous immunotherapy market they created.
Building the framework for vertical integration while keeping those costs off the balance sheet really to me seems like an adept strategy. Management constructed manufacturing options for DCVax in the marketplace which did not exist before Linda Powers erected those producers. The fledgling CAR-T are flailing seeking the same outcome which we have made for ourselves at pennies on the dollar. Yet some need to complain as the golden goose lays her eggs.
Gilead would love to have had a Cognate like entity or process in place to solve their manufacturing problems that exist still with Yescarta. It's really laughable that you so casually dismiss the monumental achievements which Linda Powers and Les Goldman have delivered for NWBO shareholders.
RTOR isn't a public process.
Management cannot force academics to write faster, regulators to approve sooner, or erase supply chain challenges though sending a tweet.
They can continue to soldier on through the adversity while ignoring the naysayers from the peanut gallery.
Thankfully shorts are irrelevant as DCVax will be approved this year.
Linda and the folks at Toucan helped the scientists build out the manufacturing process which didn't exist before they came to Northwest Biotherapeutics. Thank the lord we have them on our side.
Thank you miltong.
I have never felt more positive about Northwest Biotherapeutics.